Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -16.86%1.61B | -25.80%940.42M | -5.75%525.44M | -2.32%2.59B | -1.40%1.94B | 1.27B | -12.16%557.5M | -8.09%2.65B | 1.96B | 13.87%634.67M |
| Operating revenue | -16.86%1.61B | -25.80%940.42M | -5.75%525.44M | -2.32%2.59B | -1.40%1.94B | --1.27B | -12.16%557.5M | -8.09%2.65B | --1.96B | 13.87%634.67M |
| Other operating revenue | ---- | -5.33%89.84M | ---- | -24.83%205.22M | ---- | --94.9M | ---- | -30.09%273M | --181.13M | ---- |
| Total operating cost | -17.48%1.5B | -23.79%903.14M | -5.53%491.42M | -0.85%2.44B | -0.86%1.81B | 1.19B | 520.19M | -6.77%2.46B | 1.83B | |
| Operating cost | -17.28%1.39B | -24.19%830.06M | -6.93%441.3M | -0.79%2.25B | 0.29%1.68B | --1.09B | --474.16M | -6.51%2.27B | --1.68B | ---- |
| Operating tax surcharges | 30.66%6.12M | 22.82%4.37M | 38.87%3.27M | 46.99%6.79M | 34.75%4.69M | --3.56M | --2.35M | -4.58%4.62M | --3.48M | ---- |
| Operating expense | -26.97%7.81M | -32.09%5.29M | -12.79%2.28M | 65.21%15.15M | 68.96%10.69M | --7.78M | --2.61M | -6.31%9.17M | --6.33M | ---- |
| Administration expense | -8.54%31.43M | -0.70%23.68M | 6.78%11.7M | 2.84%47.36M | 4.13%34.37M | --23.84M | --10.96M | 16.09%46.05M | --33M | ---- |
| Financial expense | -118.77%-2.82M | -151.88%-5.25M | -109.84%-786.37K | -42.88%21.6M | -50.42%15.02M | --10.12M | --7.99M | 51.51%37.82M | --30.3M | ---- |
| -Interest expense (Financial expense) | -53.79%9.17M | -50.33%6.9M | -63.18%3.34M | -39.99%24.71M | -43.41%19.85M | --13.9M | --9.08M | 23.38%41.18M | --35.08M | ---- |
| -Interest Income (Financial expense) | 53.19%-1.62M | 59.71%-1.06M | 59.60%-585.23K | -180.89%-3.87M | -369.33%-3.46M | ---2.63M | ---1.45M | 54.91%-1.38M | ---737.81K | ---- |
| Research and development | -6.03%61.39M | 0.13%44.99M | 52.23%33.65M | 3.99%96.63M | -15.63%65.33M | --44.93M | --22.1M | -29.54%92.92M | --77.43M | ---- |
| Credit Impairment Loss | -305.98%-3.28M | 206.03%964.84K | 165.10%203.61K | -44.69%644.14K | -405.96%-806.93K | ---909.93K | ---312.78K | 104.59%1.16M | --263.74K | ---- |
| Asset Impairment Loss | 11.81%-16.73M | 34.81%-11.36M | -184.79%-17.47M | -19.07%-19.77M | -26.69%-18.97M | ---17.43M | ---6.13M | -9.95%-16.6M | ---14.97M | ---- |
| Other net revenue | 227.18%14.05M | 226.47%16.71M | 156.72%2.31M | -20.04%-9.74M | -4.97%-11.05M | -13.21M | -4.07M | 49.55%-8.11M | -10.52M | 0 |
| Invest income | --4M | --2.17M | --662.89K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | 94.81%-183.72K | 94.61%-194.67K | ---91.12K | -1,944.89%-3.54M | -3,863.51%-3.54M | ---3.61M | ---- | -224.67%-172.97K | ---89.24K | ---- |
| Other revenue | 146.54%30.24M | 187.62%25.13M | 699.00%19M | 72.37%12.92M | 186.95%12.27M | --8.74M | --2.38M | -69.36%7.49M | --4.27M | ---- |
| Operating profit | 13.61%128.46M | -21.84%53.99M | 9.27%36.33M | -23.09%140.99M | -9.82%113.07M | 69.07M | -13.13%33.25M | -20.37%183.31M | 125.38M | 17.28%38.27M |
| Add:Non operating Income | 176.97%1.3M | 60,424.41%1.29M | 300.86%4.21K | 170.10%2.89M | 831.28%469.64K | --2.14K | --1.05K | -76.45%1.07M | --50.43K | ---- |
| Less:Non operating expense | 177.34%92.25K | 226.72%56.43K | -22.22%3.75K | -97.19%33.26K | -97.19%33.26K | --17.27K | --4.82K | 248.94%1.18M | --1.18M | ---- |
| Total profit | 14.24%129.67M | -20.03%55.22M | 9.29%36.33M | -21.48%143.85M | -8.64%113.51M | 69.05M | -13.18%33.24M | -21.85%183.2M | 124.25M | 17.35%38.29M |
| Less:Income tax cost | 41.45%9.86M | -49.18%1.77M | -72.90%446.9K | -46.06%7.76M | -16.73%6.97M | --3.48M | --1.65M | 24.38%14.39M | --8.37M | ---- |
| Net profit | 12.46%119.81M | -18.48%53.46M | 13.58%35.88M | -19.38%136.09M | -8.06%106.54M | 65.57M | -13.22%31.59M | -24.25%168.81M | 115.88M | 11.23%36.41M |
| Net profit from continuing operation | 12.46%119.81M | -18.48%53.46M | 13.58%35.88M | -19.38%136.09M | -8.06%106.54M | --65.57M | --31.59M | -24.25%168.81M | --115.88M | ---- |
| Net profit of parent company owners | 12.46%119.81M | -18.48%53.46M | 13.58%35.88M | -19.38%136.09M | -8.06%106.54M | --65.57M | -13.22%31.59M | -24.25%168.81M | --115.88M | 11.23%36.41M |
| Earning per share | ||||||||||
| Basic earning per share | -16.67%0.45 | -39.39%0.2 | -12.50%0.14 | -18.82%0.69 | -6.90%0.54 | --0.33 | --0.16 | -24.11%0.85 | --0.58 | ---- |
| Diluted earning per share | -16.67%0.45 | -39.39%0.2 | -12.50%0.14 | -18.82%0.69 | -6.90%0.54 | --0.33 | --0.16 | -24.11%0.85 | --0.58 | ---- |
| Other composite income | -53.53%13.36K | 59.82%-28.28K | 72.94%-14.24K | -590.42%-110.46K | 189.63%28.75K | -70.39K | -52.62K | 1.44%-16K | -32.08K | |
| Other composite income of parent company owners | -53.53%13.36K | 59.82%-28.28K | 72.94%-14.24K | -590.42%-110.46K | 189.63%28.75K | ---70.39K | ---52.62K | 1.44%-16K | ---32.08K | ---- |
| Total composite income | 12.44%119.83M | -18.44%53.43M | 13.72%35.87M | -19.44%135.97M | -8.01%106.57M | 65.5M | 31.54M | -24.25%168.79M | 115.84M | |
| Total composite income of parent company owners | 12.44%119.83M | -18.44%53.43M | 13.72%35.87M | -19.44%135.97M | -8.01%106.57M | --65.5M | --31.54M | -24.25%168.79M | --115.84M | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.